Resource Logo

Characteristics of women with TB and AIDS in New York City.


HIV Infect Women Conf. 1995 Feb 22-24;:P91. Unique Identifier : AIDSLINE

Objective: To describe the sociodemographic and clinical characteristics of women who have TB and AIDS in NYC. Methods: From the NYC AIDS Surveillance System we randomly selected 1,020 patients with a first episode of TB after 1990. This report is restricted to 188 cases collected thus far from 8 of the hospitals with the largest TB caseloads. Data were abstracted from medical records and the NYCDOH TB Registry. Results: Women comprised 22% of the sample. At the time of the TB evaluation, their mean age was 36 years (vs 39 in men, p=.001). 66% of the women were African American, 27% Hispanic and 7% white, similar to the men. Twice as many women as men were homeless when evaluated for their TB (26% vs. 13%) [p=.03]. Women and men did not differ in history of injection drug use (55% vs 58%, p=.82), but more women reported noninjection cocaine use (48% vs 30%, p=.04). Women and men were similar in terms of site of TB (84% vs. 82% pulmonary), resistance to greater than or equal to 1 TB drugs (34% both), and TB as the first AIDS defining illness (75% vs 73%). Only 7% of the women (vs 18% men, p=.08) presented with a concurrent AIDS defining illness. Based on life table estimates, at 3 months from TB diagnosis, 14% of women and 16% of men had died; at 2 years, mortality was 28% and 52% respectively (p=.02). Conclusion: Women with TB and AIDS in this sample differed from men on some social factors. Their 2-year survival was significantly better and further investigation is needed to understand why.

Adult *AIDS-Related Opportunistic Infections/DIAGNOSIS Female Human Male New York City Socioeconomic Factors *Tuberculosis, Pulmonary/COMPLICATIONS/DIAGNOSIS ABSTRACT


Information in this article was accurate in December 30, 1995. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.